PYXUS INTERNATIONAL, INC. (PYYX) stock intrinsic value fair value estimate & owner earnings analysis

Pyxus International (formerly Alliance One International) is one of the two large independent leaf tobacco merchants in the world. It contracts with farmers in more than fifteen countries, including Brazil, Zimbabwe, Malawi, Tanzania, Indonesia, India, Argentina, the United States and Turkey. It buys the crop, processes and packs it, and sells it to cigarette makers. Philip Morris International, China National Tobacco Corporation and Japan Tobacco International each take more than 10% of sales. Revenue was $2.41 billion in the year to March 2026, down 2.8% from $2.48 billion because crop prices in Africa were lower. Gross margin was about 14%. The business earns a thin spread on a very large, seasonal working-capital cycle. It has to pay for an entire year's crop months before it is paid. That cycle is funded with about $477 million of short-term foreign seasonal credit lines and the sale of roughly $650 million a year of receivables to banks. What the business earns. We measure cash profit as operating cash flow with the swings in inventory and receivables removed, less stock-based pay and the capital spending needed to maintain today's plants. On that basis Pyxus made a loss of $0.43 a share in fiscal 2022 and a loss of $0.97 a share in fiscal 2023, $0.16 in fiscal 2024, $0.75 in fiscal 2025 and $0.48 in fiscal 2026. These are lower than the figures we published before. In rebuilding the series directly from reported operating cash flow, we found a recurring cash outflow line, listed as 'other, net', of about $7 to $13 million a year that had not been carried through. Cash profit fell about 36% in fiscal 2026. That compares with a modest decline built into the first year of our base case, so the base case does not assume a rebound. Because interest is so large relative to profit here, we value the business before its lenders, then take off the debt. In fiscal 2026 the company paid $119 million of cash interest. Adding that back, the business generated about $132 million, or $5.08 a share, before paying any lender. That figure was $134 million in fiscal 2025 and $113 million in fiscal 2024. We anchor on the fiscal 2024 to 2026 years, the period since the February 2023 debt exchange reset the balance sheet. Fiscal 2022 and 2023 ($69 to $76 million) were the immediate aftermath of the 2020 bankruptcy, and we treat them as the trough of this business's own cycle rather than as normal. About half of the pre-interest cash flow, roughly $69 million last year, goes to interest on the seasonal crop lines. That cost is part of running the business and we treat it that way in every case. The remainder, about $63 million, is what is left to service the long-term secured debt, and that debt is the central issue. The debt. At March 2026 Pyxus owed about $457 million of secured term debt, all of it due on December 31, 2027. That consists of $148 million of 8.5% notes and about $309 million of Intabex and Pyxus term loans paying SOFR plus 8%, about 12.4%. The blended cash cost is about 11%, or $51 million a year. The ABL revolving facility falls due 90 days before that date if the term debt is still outstanding. The company held $134 million of cash at March 2026 and $176 million at June 2026. Much of that is seasonal cash in overseas subsidiaries that is needed to buy the next crop, so we credit only about $67 million as surplus. We also deduct $7 million for minority partners' stakes. The positives are real. Pyxus has stayed within all its covenants. In fiscal 2025 it bought back $34 million of notes at a 23% discount and term loans at a 12% discount. It repaid its older 2024 notes in cash. Management has said dealing with the 2027 maturity is a priority. But the most recent annual report and quarterly filing disclose no refinancing transaction, and the 10-K warns the debt may only be renewable on more expensive terms. Base case: worth about $1.85 billion before lenders, owing about $1.71 billion, leaving about $7.65 a share. Pre-interest cash flow starts about 2% below fiscal 2026 and then fades about 1% a year with global cigarette volumes. Those volumes are the company's own named long-term risk, with demand in developed markets shrinking. In this case the December 2027 debt is refinanced at about 11%, close to its current cost. The about $63 million a year left after seasonal-line interest covers the term-debt interest about 1.2 to 1.6 times. That cash slowly repays the debt, from $457 million to about $300 million by year ten. Of the $1.71 billion owed, about $960 million is the present cost of the seasonal crop financing and about $750 million is the secured term debt. We credit no growth in this case. Volumes in South America and processing work in Africa and North America rose last year, but there are no multi-year contracts or new capacity in the filings that would put growth in the bag. Bull case: worth about $2.07 billion, owing about $1.70 billion, leaving about $16.54 a share. In this case the fiscal 2025 level of about $134 million is held, fading only 0.5% a year. That reflects the higher-margin processing work and tighter leaf supply the company has reported. The 2027 debt is refinanced at about 9.5%, and term debt falls to under $180 million within ten years. We did not credit volume gains from competitors leaving the market, because nothing in the filings documents them. Bear case: worth about $1.46 billion, owing about $1.79 billion, leaving roughly minus $12.84 a share. In other words, in this case the company owes about $335 million more than the business is worth. The bear case uses the company's own record. In fiscal 2022 and 2023, pre-interest cash flow fell to about $70 million when crop costs and customer orders moved against it. We repeat that kind of downturn for three years, starting just as the December 2027 maturity has to be refinanced, at about 13%, which reflects the 12.4% the term loans already pay. With seasonal-line interest taken out first, the business could then cover only about 60% of its term-debt interest. The debt grows instead of shrinking, and recovery after the downturn is not enough to get it back down. In practice that path ends in another restructuring, as happened in 2020, with existing shareholders largely wiped out. That is a real possibility for this business, not an imagined one. Margin-of-safety price. We are reasonably confident in the level of cash the business generates before lenders. It has been $113 to $134 million in each of the last three years, on revenue of $2.0 to $2.5 billion. We are not confident about what will be left for shareholders, because nearly all of the equity value depends on one event: refinancing $457 million on December 31, 2027. The worst plausible outcome is a weak crop year or a pullback by a major customer arriving at the same time as that maturity. The company's history says the structure does not survive that. The 2020 bankruptcy cancelled the old shares, and three customers buy most of the leaf. The two things we are most likely to be wrong about are the refinancing rate and how long cash profit holds near its recent peak. If the debt is refinanced at about 12% instead of 11%, the base value drops to roughly $1 to $2 a share. If cash profit holds at the fiscal 2026 level instead of fading, the base value is about $6. The company pays no dividend and its covenants restrict paying one, so shareholders receive nothing while waiting. Any return has to come from debt repayment raising the value of the equity, which takes years at about $10 to $30 million a year. Before the refinancing is done, no margin-of-safety price is supportable, because the bear outcome is a near-total loss. Once the 2027 debt has been refinanced to 2030 or later at no more than about 12% and without new shares, the bear case falls back toward the downturn-only outcome. At that point the margin-of-safety price is $3.50 a share. From that price, debt paydown that brings the value back to the base case over an assumed holding period of about four years implies roughly 20% a year. A shallower downturn than the one in our bear case would still leave the shares worth more than $3.50, though a repeat of fiscal 2022 to 2023 would not. Other notes. Pyxus sells receivables to banks for cash, and part of the price, about $200 million last year, is collected later. Those collections appear in investing cash flow, not operating cash flow. We treat them as part of the crop-funding cycle, not as earnings, so they add nothing to our figures. The shares trade over the counter, and the company says no broker makes a market in them, so trading can be thin and prices can move sharply. A small group of large holders controls a significant share of the stock.